Skip to main content
Erschienen in: Endocrine 2/2017

07.09.2017 | Original Article

Dyslipidemia incidence and the trend of lipid parameters changes in women with history of gestational diabetes: a 15-year follow-up study

verfasst von: Sonia Minooee, Fahimeh Ramezani Tehrani, Maryam Rahmati, Mohammad Ali Mansournia, Fereidoun Azizi

Erschienen in: Endocrine | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Evidence shows that patients with gestational diabetes mellitus (GDM) may exhibit features of dyslipidemic phenotype later in life. We aimed to examine and compare dyslipidemia incidence rate and the trend of lipid changes over a 15-years follow-up between the women with the history of GDM and their healthy peers.

Methods

This longitudinal study included 289 patients with GDM and 1183 women without GDM, aged 20–50 years. Pooled logistic regression model was utilized to estimate odds ratio of dyslipidemia. The generalized estimating equation was used to evaluate the trend of lipid parameters changes over time.

Results

Person-time dyslipidemia incidence rate in women with previous GDM was 0.067 (CI: 0.038, 0.096) with a median progression time of 2.13 years and for those without GDM was 0.059 (CI: 0.046, 0.072) with the median time of 2.31 years (\(p - valu{e_{comparison}}\) = 0.214). The generalized estimating equation (GEE) analysis revealed no significant difference in trend changes of lipid profiles between two groups.

Conclusions

Lipid disorder after GDM might be more influenced by other variables (BMI, anthropometric features, and smoking/lifestyle habits) rather than by the GDM status alone. Lipid profile changes of GDM women do not become significantly worse than their non-GDM counterparts, as time progresses.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat A. Kautzky-Willer, M. Krssak, C. Winzer, G. Pacini, A. Tura, S. Farhan, O. Wagner, G. Brabant, R. Horn, H. Stingl, B. Schneider, W. Waldhausl, M. Roden, Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 52(2), 244–251 (2003)CrossRefPubMed A. Kautzky-Willer, M. Krssak, C. Winzer, G. Pacini, A. Tura, S. Farhan, O. Wagner, G. Brabant, R. Horn, H. Stingl, B. Schneider, W. Waldhausl, M. Roden, Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 52(2), 244–251 (2003)CrossRefPubMed
2.
Zurück zum Zitat L. Bellamy, J.P. Casas, A.D. Hingorani, D. Williams, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet (London, England) 373(9677), 1773–1779 (2009)CrossRef L. Bellamy, J.P. Casas, A.D. Hingorani, D. Williams, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet (London, England) 373(9677), 1773–1779 (2009)CrossRef
3.
Zurück zum Zitat D.A. Enquobahrie, M.A. Williams, C. Qiu, D.A. Luthy, Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res. Clin. Pract. 70(2), 134–142 (2005)CrossRefPubMed D.A. Enquobahrie, M.A. Williams, C. Qiu, D.A. Luthy, Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res. Clin. Pract. 70(2), 134–142 (2005)CrossRefPubMed
4.
Zurück zum Zitat E.P. Gunderson, V. Chiang, M.J. Pletcher, D.R. Jacobs, C.P. Quesenberry, S. Sidney, C.E. Lewis, History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the coronary artery risk development in young adults study. J. Am. Heart Assoc. 3(2), e000490 (2014)CrossRefPubMedPubMedCentral E.P. Gunderson, V. Chiang, M.J. Pletcher, D.R. Jacobs, C.P. Quesenberry, S. Sidney, C.E. Lewis, History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the coronary artery risk development in young adults study. J. Am. Heart Assoc. 3(2), e000490 (2014)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat E. Noctor, C. Crowe, L.A. Carmody, B. Kirwan, A. O’Dea, L.G. Glynn, B.E. McGuire, P.M. O’Shea, F.P. Dunne, ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International association of diabetes in pregnancy study groups criteria. Acta Diabetol. 52(1), 153–160 (2015)CrossRefPubMed E. Noctor, C. Crowe, L.A. Carmody, B. Kirwan, A. O’Dea, L.G. Glynn, B.E. McGuire, P.M. O’Shea, F.P. Dunne, ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International association of diabetes in pregnancy study groups criteria. Acta Diabetol. 52(1), 153–160 (2015)CrossRefPubMed
6.
Zurück zum Zitat P. Chen, S. Wang, J. Ji, A. Ge, C. Chen, Y. Zhu, N. Xie, Y. Wang, Risk factors and management of gestational diabetes. Cell Biochem. Biophys. 71(2), 689–694 (2015)CrossRefPubMed P. Chen, S. Wang, J. Ji, A. Ge, C. Chen, Y. Zhu, N. Xie, Y. Wang, Risk factors and management of gestational diabetes. Cell Biochem. Biophys. 71(2), 689–694 (2015)CrossRefPubMed
7.
Zurück zum Zitat A.S. Gilinsky, A.F. Kirk, A.R. Hughes, R.S. Lindsay, Lifestyle interventions for type 2 diabetes prevention in women with prior gestational diabetes: a systematic review and meta-analysis of behavioural, anthropometric and metabolic outcomes. Prev. Med. Rep. 2, 448–461 (2015)CrossRefPubMedPubMedCentral A.S. Gilinsky, A.F. Kirk, A.R. Hughes, R.S. Lindsay, Lifestyle interventions for type 2 diabetes prevention in women with prior gestational diabetes: a systematic review and meta-analysis of behavioural, anthropometric and metabolic outcomes. Prev. Med. Rep. 2, 448–461 (2015)CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat M. Rizzo, K. Berneis, Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? J. Atheroscler. Thromb. 12(5), 237–239 (2005)CrossRefPubMed M. Rizzo, K. Berneis, Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? J. Atheroscler. Thromb. 12(5), 237–239 (2005)CrossRefPubMed
9.
Zurück zum Zitat G. Di Cianni, C. Lencioni, L. Volpe, A. Ghio, I. Cuccuru, G. Pellegrini, L. Benzi, R. Miccoli, S. Del Prato, C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes/Metab. Res. Rev. 23(2), 135–140 (2007)CrossRef G. Di Cianni, C. Lencioni, L. Volpe, A. Ghio, I. Cuccuru, G. Pellegrini, L. Benzi, R. Miccoli, S. Del Prato, C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes/Metab. Res. Rev. 23(2), 135–140 (2007)CrossRef
10.
Zurück zum Zitat R.S. Padwal, A.M. Sharma, Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome. Can. J. Cardiol. 26(Suppl C), 18C–20C (2010)CrossRefPubMedPubMedCentral R.S. Padwal, A.M. Sharma, Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome. Can. J. Cardiol. 26(Suppl C), 18C–20C (2010)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat H. Fadl, A. Magnuson, I. Ostlund, S. Montgomery, U. Hanson, E. Schwarcz, Gestational diabetes mellitus and later cardiovascular disease: a Swedish population based case-control study. BJOG: Int. J. Obstet. Gynaecol. 121(12), 1530–1536 (2014)CrossRef H. Fadl, A. Magnuson, I. Ostlund, S. Montgomery, U. Hanson, E. Schwarcz, Gestational diabetes mellitus and later cardiovascular disease: a Swedish population based case-control study. BJOG: Int. J. Obstet. Gynaecol. 121(12), 1530–1536 (2014)CrossRef
12.
Zurück zum Zitat R. Cifkova, A. Krajcoviechova, Dyslipidemia and cardiovascular disease in women. Curr. Cardiol. Rep. 17(7), 609 (2015)CrossRefPubMed R. Cifkova, A. Krajcoviechova, Dyslipidemia and cardiovascular disease in women. Curr. Cardiol. Rep. 17(7), 609 (2015)CrossRefPubMed
13.
Zurück zum Zitat F. Azizi, A. Ghanbarian, A.A. Momenan, F. Hadaegh, P. Mirmiran, M. Hedayati, Y. Mehrabi, S. Zahedi-Asl, Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials 10, 5 (2009)CrossRefPubMedPubMedCentral F. Azizi, A. Ghanbarian, A.A. Momenan, F. Hadaegh, P. Mirmiran, M. Hedayati, Y. Mehrabi, S. Zahedi-Asl, Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials 10, 5 (2009)CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat F. Ramezani Tehrani, S.A. Montazeri, F. Hosseinpanah, L. Cheraghi, H. Erfani, M. Tohidi, F. Azizi, Trend of cardio-metabolic risk factors in polycystic ovary syndrome: a population-based prospective cohort study. PLoS ONE 10(9), e0137609 (2015)CrossRefPubMedPubMedCentral F. Ramezani Tehrani, S.A. Montazeri, F. Hosseinpanah, L. Cheraghi, H. Erfani, M. Tohidi, F. Azizi, Trend of cardio-metabolic risk factors in polycystic ovary syndrome: a population-based prospective cohort study. PLoS ONE 10(9), e0137609 (2015)CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat F.R. Tehrani, S. Hashemi, M. Hasheminia, F. Azizi, Follow-up of women with gestational diabetes in the Tehran lipid and glucose study (TLGS): a population-based cohort study. J. Obstet. Gynaecol. Res. 38(4), 698–704 (2012)CrossRefPubMed F.R. Tehrani, S. Hashemi, M. Hasheminia, F. Azizi, Follow-up of women with gestational diabetes in the Tehran lipid and glucose study (TLGS): a population-based cohort study. J. Obstet. Gynaecol. Res. 38(4), 698–704 (2012)CrossRefPubMed
16.
Zurück zum Zitat Y. Chen, X. Zhang, B. Pan, X. Jin, H. Yao, B. Chen, Y. Zou, J. Ge, H. Chen, A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 9, 52 (2010)CrossRefPubMedPubMedCentral Y. Chen, X. Zhang, B. Pan, X. Jin, H. Yao, B. Chen, Y. Zou, J. Ge, H. Chen, A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 9, 52 (2010)CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat K.G. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 15(7), 539–553 (1998)CrossRefPubMed K.G. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 15(7), 539–553 (1998)CrossRefPubMed
18.
Zurück zum Zitat J.R. Gavin III, K.G.M.M. Alberti, M.B. Davidson, R.A. DeFronzo, Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20(7), 1183–1197 (1997)CrossRef J.R. Gavin III, K.G.M.M. Alberti, M.B. Davidson, R.A. DeFronzo, Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20(7), 1183–1197 (1997)CrossRef
19.
Zurück zum Zitat C. Lenfant, J.I. Cleeman, T.G. Ganiats, G. Graham, R.E. Kleinman, P. Hixon, R.C. Pasternak, G.T. Gau, H. Preuss, T.C. Peng, R.A. Jordan, L.H. Kuller, A.J. Garber, L.V. Horn, S.M. Grundy, S. Cornett, Y.D. Coble, M. Clearfield, J.M. McKenney, S. Havas, D. Vardell, K. Watson, J. Mitten, G.J. Wilson, L. Burnes-Bolton, L.T. Clark, D. Lansing, D.O. Fedder, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19), 2486–2497 (2001)CrossRef C. Lenfant, J.I. Cleeman, T.G. Ganiats, G. Graham, R.E. Kleinman, P. Hixon, R.C. Pasternak, G.T. Gau, H. Preuss, T.C. Peng, R.A. Jordan, L.H. Kuller, A.J. Garber, L.V. Horn, S.M. Grundy, S. Cornett, Y.D. Coble, M. Clearfield, J.M. McKenney, S. Havas, D. Vardell, K. Watson, J. Mitten, G.J. Wilson, L. Burnes-Bolton, L.T. Clark, D. Lansing, D.O. Fedder, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19), 2486–2497 (2001)CrossRef
20.
Zurück zum Zitat K.-Y. Liang, S.L. Zeger, Longitudinal data analysis using generalized linear models. Biometrika 73(1), 13–22 (1986)CrossRef K.-Y. Liang, S.L. Zeger, Longitudinal data analysis using generalized linear models. Biometrika 73(1), 13–22 (1986)CrossRef
21.
Zurück zum Zitat S. Brewster, B. Zinman, R. Retnakaran, J.S. Floras, Cardiometabolic consequences of gestational dysglycemia. J. Am. Coll. Cardiol. 62(8), 677–684 (2013)CrossRefPubMed S. Brewster, B. Zinman, R. Retnakaran, J.S. Floras, Cardiometabolic consequences of gestational dysglycemia. J. Am. Coll. Cardiol. 62(8), 677–684 (2013)CrossRefPubMed
22.
Zurück zum Zitat J.W. Li, S.Y. He, P. Liu, L. Luo, L. Zhao, Y.B. Xiao, Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis. BMC Cardiovasc. Disord. 14, 132 (2014)CrossRefPubMedPubMedCentral J.W. Li, S.Y. He, P. Liu, L. Luo, L. Zhao, Y.B. Xiao, Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis. BMC Cardiovasc. Disord. 14, 132 (2014)CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat C.M. Freire, F.B. Barbosa, M.C. de Almeida, P.A. Miranda, M.M. Barbosa, A.I. Nogueira, M.M. Guimaraes, C. Nunes Mdo, A. Ribeiro-Oliveira Jr., Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome - a case control study. Cardiovasc. Diabetol. 11, 59 (2012)CrossRefPubMedPubMedCentral C.M. Freire, F.B. Barbosa, M.C. de Almeida, P.A. Miranda, M.M. Barbosa, A.I. Nogueira, M.M. Guimaraes, C. Nunes Mdo, A. Ribeiro-Oliveira Jr., Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome - a case control study. Cardiovasc. Diabetol. 11, 59 (2012)CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat O. Ajala, L.A. Jensen, E. Ryan, C. Chik, Women with a history of gestational diabetes on long-term follow up have normal vascular function despite more dysglycemia, dyslipidemia and adiposity. Diabetes Res. Clin. Pract. 110(3), 309–314 (2015)CrossRefPubMed O. Ajala, L.A. Jensen, E. Ryan, C. Chik, Women with a history of gestational diabetes on long-term follow up have normal vascular function despite more dysglycemia, dyslipidemia and adiposity. Diabetes Res. Clin. Pract. 110(3), 309–314 (2015)CrossRefPubMed
25.
Zurück zum Zitat S.L. Kjos, T.A. Buchanan, M. Montoro, A. Coulson, J.H. Mestman, Serum lipids within 36 mo of delivery in women with recent gestational diabetes. Diabetes 40(Suppl 2), 142–146 (1991)CrossRefPubMed S.L. Kjos, T.A. Buchanan, M. Montoro, A. Coulson, J.H. Mestman, Serum lipids within 36 mo of delivery in women with recent gestational diabetes. Diabetes 40(Suppl 2), 142–146 (1991)CrossRefPubMed
26.
Zurück zum Zitat E. Koukkou, G.F. Watts, C. Lowy, Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J. Clin. Pathol. 49(8), 634–637 (1996)CrossRefPubMedPubMedCentral E. Koukkou, G.F. Watts, C. Lowy, Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J. Clin. Pathol. 49(8), 634–637 (1996)CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat A.S. Ryan, J.C. McLenithan, G.M. Zietowski, Accelerated metabolic susceptibility to type 2 diabetes in older women with a history of gestational diabetes. Endocr. Connect. 2(2), 79–86 (2013)CrossRefPubMedPubMedCentral A.S. Ryan, J.C. McLenithan, G.M. Zietowski, Accelerated metabolic susceptibility to type 2 diabetes in older women with a history of gestational diabetes. Endocr. Connect. 2(2), 79–86 (2013)CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat A. Verma, C.M. Boney, R. Tucker, B.R.: Vohr, Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J. Clin. Endocrinol. Metabol. 87(7), 3227–3235 (2002)CrossRef A. Verma, C.M. Boney, R. Tucker, B.R.: Vohr, Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J. Clin. Endocrinol. Metabol. 87(7), 3227–3235 (2002)CrossRef
29.
Zurück zum Zitat C.H. Meyers-Seifer, B.R. Vohr, Lipid levels in former gestational diabetic mothers. Diabetes Care 19(12), 1351–1356 (1996)CrossRefPubMed C.H. Meyers-Seifer, B.R. Vohr, Lipid levels in former gestational diabetic mothers. Diabetes Care 19(12), 1351–1356 (1996)CrossRefPubMed
30.
Zurück zum Zitat S. Forbes, I.F. Godsland, S.D. Taylor-Robinson, J.D. Bell, E.L. Thomas, N. Patel, G. Hamilton, K.H. Parker, I. Marshall, C.D. Gray, D. Bedford, M. Caslake, B.R. Walker, D.G. Johnston, A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. Diabetologia 56(9), 2021–2033 (2013)CrossRefPubMed S. Forbes, I.F. Godsland, S.D. Taylor-Robinson, J.D. Bell, E.L. Thomas, N. Patel, G. Hamilton, K.H. Parker, I. Marshall, C.D. Gray, D. Bedford, M. Caslake, B.R. Walker, D.G. Johnston, A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. Diabetologia 56(9), 2021–2033 (2013)CrossRefPubMed
31.
Zurück zum Zitat R. Retnakaran, Y. Qi, P.W. Connelly, M. Sermer, A.J. Hanley, B. Zinman, The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk. J. Clin. Endocrinol. Metab. 95(9), 4345–4353 (2010)CrossRefPubMed R. Retnakaran, Y. Qi, P.W. Connelly, M. Sermer, A.J. Hanley, B. Zinman, The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk. J. Clin. Endocrinol. Metab. 95(9), 4345–4353 (2010)CrossRefPubMed
32.
Zurück zum Zitat M. Arca, G. Pigna, C. Favoccia, Mechanisms of diabetic dyslipidemia: relevance for atherogenesis. Curr. Vasc. Pharmacol. 10(6), 684–686 (2012)CrossRefPubMed M. Arca, G. Pigna, C. Favoccia, Mechanisms of diabetic dyslipidemia: relevance for atherogenesis. Curr. Vasc. Pharmacol. 10(6), 684–686 (2012)CrossRefPubMed
33.
Zurück zum Zitat M. Adiels, J. Boren, M.J. Caslake, P. Stewart, A. Soro, J. Westerbacka, B. Wennberg, S.O. Olofsson, C. Packard, M.R. Taskinen, Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 25(8), 1697–1703 (2005)CrossRefPubMed M. Adiels, J. Boren, M.J. Caslake, P. Stewart, A. Soro, J. Westerbacka, B. Wennberg, S.O. Olofsson, C. Packard, M.R. Taskinen, Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 25(8), 1697–1703 (2005)CrossRefPubMed
34.
Zurück zum Zitat B. Verges, Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. Atherosclerosis 211(2), 353–360 (2010)CrossRefPubMed B. Verges, Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. Atherosclerosis 211(2), 353–360 (2010)CrossRefPubMed
35.
Zurück zum Zitat C. Capula, E. Chiefari, A. Vero, D.P. Foti, A. Brunetti, R. Vero, Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 105(2), 223–230 (2014)CrossRefPubMed C. Capula, E. Chiefari, A. Vero, D.P. Foti, A. Brunetti, R. Vero, Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 105(2), 223–230 (2014)CrossRefPubMed
36.
Zurück zum Zitat M. Barzin, S. Keihani, F. Hosseinpanah, S. Serahati, S. Ghareh, F. Azizi, Rising trends of obesity and abdominal obesity in 10 years of follow-up among Tehranian adults: Tehran lipid and glucose study (TLGS). Public Health Nutr. 18(16), 2981–2989 (2015)CrossRefPubMed M. Barzin, S. Keihani, F. Hosseinpanah, S. Serahati, S. Ghareh, F. Azizi, Rising trends of obesity and abdominal obesity in 10 years of follow-up among Tehranian adults: Tehran lipid and glucose study (TLGS). Public Health Nutr. 18(16), 2981–2989 (2015)CrossRefPubMed
Metadaten
Titel
Dyslipidemia incidence and the trend of lipid parameters changes in women with history of gestational diabetes: a 15-year follow-up study
verfasst von
Sonia Minooee
Fahimeh Ramezani Tehrani
Maryam Rahmati
Mohammad Ali Mansournia
Fereidoun Azizi
Publikationsdatum
07.09.2017
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1413-3

Weitere Artikel der Ausgabe 2/2017

Endocrine 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.